{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:35:59Z","timestamp":1783121759454,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Phenylketonuria (PKU) is an inherited metabolic disorder characterized by reduced activity of phenylalanine hydroxylase resulting in elevated blood phenylalanine (Phe) concentration. Despite some obvious ocular changes, the disorder has been poorly recognized by ophthalmologists. Neurophysiologic tests imply prolonged reaction time correlating with increased phenylalanine blood concentrations. We aimed to test saccadic reaction time in PKU patients in dependency of blood phenylalanine concentrations.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Nineteen biochemically diagnosed PKU patients and 100 controls completed comprehensive ophthalmologic and orthoptic examinations including saccadometry by infrared based video-oculography. Peak velocity, gain, and particularly latency of reflexive saccades were compared to controls, and regression analysis was performed.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Latency of reflexive saccades was not associated with the current phenylalanine concentration. Although in 10 out of 19 patients phenylalanine concentrations were outside the age-related therapeutic range, latency differed little between PKU patients and the controls, as well as peak velocity and gain. Ocular findings occurred as partial hypopigmentation of the iris in one late diagnosed patient aged 36\u2009years, and as bilateral cataracts (possibly due to steroid intake) with refractive amblyopia, strabismus, high myopia, and glaucoma in another late diagnosed patient aged 46\u2009years. Visual acuity was reduced in eight PKU patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Saccadometry, particularly saccadic reaction time, is not useful in the monitoring of phenylketonuria. Ophthalmic examination is recommended in PKU patients, as the occurrence of ocular pathologies was relatively high.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-020-01407-7","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T14:02:58Z","timestamp":1590415378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Saccadic reaction time and ocular findings in phenylketonuria"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7989-9420","authenticated-orcid":false,"given":"Susanne","family":"Hopf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Hennermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Schmidtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"key":"1407_CR1","unstructured":"Deutsche Gesellschaft f\u00fcr Neugeborenenscreening e.V. Nationaler Screeningreport Deutschland 2016 [Internet]. Natl. Screeningreport Dtschl. 2016. Available from: http:\/\/www.screening-dgns.de\/Pdf\/Screeningreports\/DGNS-Screeningreport-d_2016.pdf."},{"key":"1407_CR2","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet Lond Engl. 2010;376:1417\u201327.","journal-title":"Lancet Lond Engl"},{"key":"1407_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(02)09334-0","volume":"360","author":"JH Walter","year":"2002","unstructured":"Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, et al. How practical are recommendations for dietary control in phenylketonuria? Lancet Lond Engl. 2002;360:55\u20137.","journal-title":"Lancet Lond Engl"},{"key":"1407_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/archopht.1983.01040020238016","volume":"101","author":"J Zwaan","year":"1983","unstructured":"Zwaan J. Eye findings in patients with phenylketonuria. Arch Ophthalmol Chic Ill 1960. 1983;101:1236\u20137.","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"1407_CR5","volume-title":"Perinatal-Ophthalmologie an der Universit\u00e4tsklinik des Saarlandes","author":"B K\u00e4smann-Kellner","year":"1998","unstructured":"K\u00e4smann-Kellner B, Sitzmann CF. Perinatal-Ophthalmologie an der Universit\u00e4tsklinik des Saarlandes; 1998."},{"key":"1407_CR6","doi-asserted-by":"publisher","first-page":"bcr2013010509","DOI":"10.1136\/bcr-2013-010509","volume":"2013","author":"MS Anwar","year":"2013","unstructured":"Anwar MS, Waddell B, O\u2019Riordan J. Neurological improvement following reinstitution of a low phenylalanine diet after 20 years in established phenylketonuria. BMJ Case Rep. 2013;2013:bcr2013010509.","journal-title":"BMJ Case Rep"},{"key":"1407_CR7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","volume":"33","author":"J Albrecht","year":"2009","unstructured":"Albrecht J, Garbade SF, Burgard P. Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev. 2009;33:414\u201321.","journal-title":"Neurosci Biobehav Rev"},{"key":"1407_CR8","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s11011-018-0267-6","volume":"33","author":"A Bartus","year":"2018","unstructured":"Bartus A, Palasti F, Juhasz E, Kiss E, Simonova E, Sumanszki C, et al. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients. Metab Brain Dis. 2018;33:1609\u201315.","journal-title":"Metab Brain Dis"},{"issue":"Pt 2","key":"1407_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/brain\/119.2.523","volume":"119","author":"A Diamond","year":"1996","unstructured":"Diamond A, Herzberg C. Impaired sensitivity to visual contrast in children treated early and continuously for phenylketonuria. Brain J Neurol. 1996;119(Pt 2):523\u201338.","journal-title":"Brain J Neurol"},{"key":"1407_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fneur.2017.00592","volume":"8","author":"E Pretegiani","year":"2017","unstructured":"Pretegiani E, Optican LM. Eye movements in Parkinson\u2019s disease and inherited Parkinsonian syndromes. Front Neurol. 2017;8:592.","journal-title":"Front Neurol"},{"key":"1407_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1249\/MSS.0000000000001307","volume":"49","author":"CJW Connell","year":"2017","unstructured":"Connell CJW, Thompson B, Turuwhenua J, Srzich A, Gant N. Effects of dopamine and norepinephrine on exercise-induced oculomotor fatigue. Med Sci Sports Exerc. 2017;49:1778\u201388.","journal-title":"Med Sci Sports Exerc"},{"key":"1407_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab. 2012;106:330\u201344.","journal-title":"Mol Genet Metab"},{"key":"1407_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13023-019-1244-9","volume":"14","author":"S Hopf","year":"2019","unstructured":"Hopf S, Pfeiffer N, Liesenfeld M, Mengel K-E, Hennermann JB, Schmidtmann I, et al. A comprehensive monocentric ophthalmic study with Gaucher disease type 3 patients: vitreoretinal lesions, retinal atrophy and characterization of abnormal saccades. Orphanet J Rare Dis. 2019;14:257.","journal-title":"Orphanet J Rare Dis"},{"key":"1407_CR14","doi-asserted-by":"publisher","first-page":"e0204008","DOI":"10.1371\/journal.pone.0204008","volume":"13","author":"S Hopf","year":"2018","unstructured":"Hopf S, Liesenfeld M, Schmidtmann I, Ashayer S, Pitz S. Age dependent normative data of vertical and horizontal reflexive saccades. PLoS One. 2018;13:e0204008.","journal-title":"PLoS One"},{"key":"1407_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112:155\u20139.","journal-title":"Psychol Bull"},{"key":"1407_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10545-010-9276-2","volume":"34","author":"C Dawson","year":"2011","unstructured":"Dawson C, Murphy E, Maritz C, Chan H, Ellerton C, Carpenter RHS, et al. Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time. J Inherit Metab Dis. 2011;34:449\u201354.","journal-title":"J Inherit Metab Dis"},{"key":"1407_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1068\/p6547","volume":"39","author":"J Halliday","year":"2010","unstructured":"Halliday J, Carpenter RHS. The effect of cognitive distraction on saccadic latency. Perception. 2010;39:41\u201350.","journal-title":"Perception."},{"key":"1407_CR18","unstructured":"Phenylketonuria Does Not Cause Cataracts - PubMed [Internet]. [cited 2020 Jan 13]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/1915521-phenylketonuria-does-not-cause-cataracts\/."},{"key":"1407_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/0013-4694(82)90026-8","volume":"53","author":"D Creel","year":"1982","unstructured":"Creel D, Buehler BA. Pattern evoked potentials in phenylketonuria. Electroencephalogr Clin Neurophysiol. 1982;53:220\u20133.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"1407_CR20","first-page":"35","volume":"145","author":"CG Azen","year":"1991","unstructured":"Azen CG, Koch R, Friedman EG, Berlow S, Coldwell J, Krause W, et al. Intellectual development in 12-year-old children treated for phenylketonuria. Am J Dis Child 1960. 1991;145:35\u20139.","journal-title":"Am J Dis Child 1960"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01407-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01407-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01407-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:16:37Z","timestamp":1621898197000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01407-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1407"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01407-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Medical Ethical Committee of the State Chamber of Medicine of Rhineland Palatinate in Mainz, Germany (reference number 837.374.14).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients or their parents\/guardians gave a written consent to publication of their anonymized clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}